Patricia Zilliox
Direttore/Membro del Consiglio presso ACTICOR BIOTECH SAS
Profilo
Patricia Zilliox is currently the President & Chief Executive Officer at Eyevensys SAS and an Independent Director at Acticor Biotech SAS.
Previously, she served as the Chief Executive Officer at Foundation Fighting Blindness Clinical Research Institute, the Senior Director-Clinical Pharma at Alcon Laboratories, Inc., and the Chief Drug Development Officer at The Foundation Fighting Blindness, Inc.
Posizioni attive di Patricia Zilliox
Società | Posizione | Inizio |
---|---|---|
ACTICOR BIOTECH SAS | Direttore/Membro del Consiglio | 26/01/2023 |
Eyevensys SAS
Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France. | Amministratore Delegato | 12/12/2017 |
Precedenti posizioni note di Patricia Zilliox
Società | Posizione | Fine |
---|---|---|
Alcon Laboratories, Inc.
Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Corporate Officer/Principal | 01/01/2011 |
Foundation Fighting Blindness Clinical Research Institute
Foundation Fighting Blindness Clinical Research Institute Financial ConglomeratesFinance Foundation Fighting Blindness Clinical Research Institute provides investment services. The company is headquartered in Columbia, MD. | Amministratore Delegato | - |
The Foundation Fighting Blindness, Inc.
The Foundation Fighting Blindness, Inc. Miscellaneous Commercial ServicesCommercial Services The Foundation Fighting Blindness, Inc. provides preventions, treatments and cures for people affected by retinitis pigmentosa, macular degeneration and usher syndrome. The firm also provides provide information on retinal degenerative diseases to all who request it, in order to increase knowledge and awareness of these diseases. It has locations in Columbia, Denver, Libertyville, New York, Plano, Raleigh and Santa Monica. The company was founded on September 16, 1971 and is headquartered in Columbia, MD. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
ACTICOR BIOTECH SAS | Health Technology |
Aziende private | 4 |
---|---|
The Foundation Fighting Blindness, Inc.
The Foundation Fighting Blindness, Inc. Miscellaneous Commercial ServicesCommercial Services The Foundation Fighting Blindness, Inc. provides preventions, treatments and cures for people affected by retinitis pigmentosa, macular degeneration and usher syndrome. The firm also provides provide information on retinal degenerative diseases to all who request it, in order to increase knowledge and awareness of these diseases. It has locations in Columbia, Denver, Libertyville, New York, Plano, Raleigh and Santa Monica. The company was founded on September 16, 1971 and is headquartered in Columbia, MD. | Commercial Services |
Foundation Fighting Blindness Clinical Research Institute
Foundation Fighting Blindness Clinical Research Institute Financial ConglomeratesFinance Foundation Fighting Blindness Clinical Research Institute provides investment services. The company is headquartered in Columbia, MD. | Finance |
Eyevensys SAS
Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France. | Commercial Services |
Alcon Laboratories, Inc.
Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Health Technology |
- Borsa valori
- Insiders
- Patricia Zilliox